Clinical Trials Directory

Trials / Completed

CompletedNCT01188928

LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)

A Phase 3 Study Comparing Once Daily Treatment With Calcipotriol 50 mcg/g Plus Betamethasone 0.5 mg/g (as Dipropionate) Topical Suspension With Betamethasone 0.5 mg/g (as Dipropionate) in the Topical Suspension Vehicle, Calcipotriol 50 mcg/g in the Topical Suspension Vehicle and the Topical Suspension Vehicle Alone in Subjects With Psoriasis Vulgaris on Non-scalp Regions of the Body (Trunk and/or Limbs)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
1,152 (actual)
Sponsor
LEO Pharma · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the efficacy and safety of Calcipotriol 50 Mcg/g Plus Betamethasone 0.5 mg/g (as Dipropionate) Topical Suspension with the active components when used individually as monotherapy in the topical suspension vehicle (betamethasone dipropionate in the topical suspension vehicle, calcipotriol in the topical suspension vehicle) and with the topical suspension vehicle alone in the treatment of psoriasis vulgaris on the non-scalp regions of the body (trunk and/or limbs) in a large phase 3 study. This comparison will ensure a more informed assessment of the benefit/risk ratio of Calcipotriol 50 Mcg/g Plus Betamethasone 0.5 mg/g (as Dipropionate) Topical Suspension while also establishing the optimal treatment duration in psoriasis vulgaris on the non-scalp regions of the body (trunk and/or limbs).

Conditions

Interventions

TypeNameDescription
DRUGCalcipotriol plus betamethasoneTopical suspension once daily for up to 8 weeks.
DRUGBetamethasone-17,21-dipropionateTopical suspension once daily for up to 8 weeks.
DRUGCalcipotrieneTopical suspension once daily for up to 8 weeks.
DRUGTopical suspension vehicleTopical suspension once daily for up to 8 weeks.

Timeline

Start date
2010-09-01
Primary completion
2011-03-01
Completion
2011-03-01
First posted
2010-08-26
Last updated
2025-03-10
Results posted
2013-04-09

Locations

59 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01188928. Inclusion in this directory is not an endorsement.